News | News By Subject | News by Disease News By Date | Search News

Tumor (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
CEO of Bay Area’s Iovance Biotherapeutics Sees TIL Technology as Best Immunotherapy Option for Treating Solid Tumors     9/7/2017
Up and Coming Scientist Gets Funding for CAR-T Startup CARMA Therapeutics     6/15/2017
Halozyme (HALO) CEO: PEGPH20 Bolsters Checkpoint Inhibitors in Preclinical Data     4/6/2017
Before We Act Impulsively on Drug Prices We Should Make Precision Policies     4/4/2017
FDA Demands Karyopharm (KPTI) Stop Enrollment of All Selinexor Trials     3/14/2017
Seattle Genetics (SGEN), Immunomedics (IMMU) Ink $2 Billion Tumor Drug Deal     2/13/2017
Bay Area’s CBT Pharma Plans to Launch 2 Phase I Trials in 2017     12/22/2016
How Fast Can Kite Pharma (KITE) File for an Approval of its Lead CAR-T?     10/20/2016
Daiichi Sankyo and Plexxikon Suspend Phase III Trial of Drug for Rare Tendon Cancer     10/19/2016
Juno (JUNO), Five Prime (FPRX) are Quiet Winners at AACR     4/25/2016
Kite Pharma (KITE) Cancer Therapy Responses in Solid Tumors Continued in Small Trial, NCI Review Halts Patient Enrollment     4/18/2016
Fluorescence Lighting Up Clinical Research     3/3/2016
Forty Seven Launches with Half of $75 Million Series A Backed by Google (GOOG) and 100+ Patents     2/26/2016
Analyst Questions High Cost of T Cell Therapies as Potential Frontline Treatment for Blood Cancers     2/25/2016
Armed with $50 Million from Google (GOOG), Celgene (CELG) and More, ARMO BioSciences Eyes Next-Gen Cancer Drug Combos     2/11/2016

News from Around the Web
A Pen That Detects Cancerous Tissue Could Help Surgeons Remove The Full Tumor, Science Translational Medicine Reveals     9/7/2017
University of Pennsylvania Researchers Engineer Macrophages To Engulf Cancer Cells In Solid Tumors     7/20/2017
New Device Detects Tumor Cells In Blood, Universitat Rovira i Virgili Study Reveals     7/18/2017
Researchers Develop Tumor-Targeting MRI Contrast Based On Human Protein, University of Massachusetts Medical School Reveals     7/10/2017
Injectable Plant-Based Nanoparticles Delay Tumor Progression, Case Western Reserve University School of Medicine Study     6/29/2017
New MRI Technique Images Glucose In Body To Spot Tumors, German Cancer Research Center (DKFZ) Study Reveals     6/29/2017
Microscope Can Scan Tumors During Surgery And Examine Cancer Biopsies In 3-D, University of Washington Study Reveals     6/28/2017
A Mechanical Trigger For Toxic Tumor Therapy, Harvard Medical School Study     6/16/2017
Scientists Move Closer To Detecting Cancer Long Before Any Symptoms Appear, GRAIL Reveals     6/12/2017
A 'Sci-Fi' Cancer Therapy Fights Brain Tumors, Study Finds     4/3/2017
Toward Glow-In-The-Dark Tumors: New Fluorescent Probe Could Light Up Cancer, Michigan Tech Study Reveals     3/30/2017
New Technique Provides Quick Tumor Diagnosis During Brain Surgeries, University of Michigan Study     2/9/2017
Miniature Brain And Skull Found Inside 16-Year-Old Girl's Ovary, Shiga Medical Centre Study     1/11/2017
How Strata Oncology Plans To Sequence 100K Tumors For Free     12/22/2016
SurgVision Displays Tumors During Surgery     12/14/2016

Press Releases
AbbVie (ABBV) And Bristol-Myers Squibb (BMY) Announce Clinical Research Collaboration To Evaluate A Therapeutic Regimen In Advanced Solid Tumors     9/22/2017
PharmaMar Starts Clinical Studies With A New Compound –PM14- In Patients With Solid Tumors     9/20/2017
DelMar Pharma Announces Issuance Of New Patent On First-In-Class DNA-Targeting Agent, VAL-083     9/20/2017
Natera Selected For Circulating Tumor DNA Study In Bladder Cancer     9/20/2017
Daiichi Sankyo Presents New Data For DS-8201 In Multiple HER2-Expressing Solid Tumors At European Society For Medical Oncology (ESMO) 2017 Congress     9/11/2017
Lycera Presents Encouraging Safety Results From Phase I ARGON Study Of LYC-55716 At The European Society For Medical Oncology (ESMO) Congress     9/11/2017
Tyme Presentation At ESMO Reported 100% Of Current Prostate Cancer Patients Have Demonstrated A Reduction In Circulating Tumor Cells, Most Becoming Undetectable     9/11/2017
Stemline (STML) Presents SL-801 Phase I Data At ESMO 2017     9/11/2017
BeiGene (BGNE) Presents Preliminary Phase I Data For BGB-A317 In Multiple Solid Tumors At The ESMO 2017 Congress     9/11/2017
Innate Pharma (IPH.PA ) Release: New Preclinical Data Further Strengthen The Rationale Of IPH5401 And Monalizumab     9/11/2017
Merck KGaA (MKGAF.PK), Darmstadt, Germany, ‘Grant For Oncology Innovation’ Awards Recognize Recipients For Pushing Boundaries In Oncology Research     9/11/2017
Foundation Medicine (FMI), Roche (RHHBY) Blood Test Could Help 'Personalize' Cancer Immunotherapy     9/8/2017
BeiGene (BGNE) Presents Preliminary Phase I/II Clinical Data On PARP Inhibitor BGB-290 In Patients With Advanced Solid Tumors At The European Society For Medical Oncology 2017 Congress     9/8/2017
Idera Pharma (IDRA) Presents Pre-Clinical Data From IMO-2125 Treatment In Combination With Ipilimumab That Demonstrates Induction Of Durable Anti-Tumor Responses Associated With Tumor-Specific Memory     9/8/2017
Advanced Accelerator Applications And FUJIFILM RI Pharma Announce First Patient In Bridging Study In Japan For Lutetium Lu 177 Dotatate* (Lutathera)     9/6/2017